Stock Analysis

Should You Be Content With SciBase Holding AB's (STO:SCIB) Earnings Growth?

OM:SCIB
Source: Shutterstock

For investors with a long-term horizon, examining earnings trend over time and against industry peers is more insightful than looking at an earnings announcement in one point in time. Investors may find my commentary, albeit very high-level and brief, on SciBase Holding AB (OM:SCIB) useful as an attempt to give more color around how SciBase Holding is currently performing. View our latest analysis for SciBase Holding

Advertisement

Commentary On SCIB's Past Performance

I use the ‘latest twelve-month’ data, which annualizes the latest 6-month earnings release, or some times, the latest annual report is already the most recent financial data. This method enables me to analyze many different companies in a uniform manner using the most relevant data points. For SciBase Holding, its most recent earnings (trailing twelve month) is -KR42.46M, which, against the prior year's level, has become less negative. Given that these figures may be fairly nearsighted, I’ve calculated an annualized five-year value for SciBase Holding's earnings, which stands at -KR47.03M. This means that, even though net income is negative, it has become less negative over the years.

OM:SCIB Income Statement Apr 12th 18
OM:SCIB Income Statement Apr 12th 18
We can further examine SciBase Holding's loss by looking at what the industry has been experiencing over the past few years. Each year, for the past five years SciBase Holding's top-line has increased by 41.49% on average, indicating that the company is in a high-growth period with expenses racing ahead revenues, leading to annual losses. Eyeballing growth from a sector-level, the SE medical equipment industry has been enduring some headwinds over the previous twelve months, leading to an average earnings drop of -12.31%. This is a major change, given that the industry has constantly been delivering a a solid growth of 14.51% in the past half a decade. This shows that while SciBase Holding is presently running a loss, whatever recent headwind the industry is enduring, the impact on SciBase Holding has been softer relative to its peers.

What does this mean?

While past data is useful, it doesn’t tell the whole story. With companies that are currently loss-making, it is always difficult to envisage what will happen in the future and when. The most useful step is to examine company-specific issues SciBase Holding may be facing and whether management guidance has steadily been met in the past. I recommend you continue to research SciBase Holding to get a better picture of the stock by looking at:

  • 1. Future Outlook: What are well-informed industry analysts predicting for SCIB’s future growth? Take a look at our free research report of analyst consensus for SCIB’s outlook.
  • 2. Financial Health: Is SCIB’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  • 3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
NB: Figures in this article are calculated using data from the trailing twelve months from 31 December 2017. This may not be consistent with full year annual report figures.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Simply Wall St analyst Simply Wall St and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.